Alyaa Al-Mughairy: Rethinking Emicizumab Low-Dose Regimens to Ensure Safe and Sustainable Patient Access
Alyaa Al-Mughairy, Pediatric Hematology Oncology Senior Consultant at Ministry of Health Oman,and National Oncology Centre at Royal Hospital, shared Michael Makris‘s post on LinkedIn, adding:
”While standard maintenance doses for Emicizumab in hemophilia A target high plasma concentrations, real-world clinical experience in low economic countries, including our own suggests a low-dose regimens can still effectively maintain a 0.0 Annual bleeding rate for spontaneous bleeds.
This suggests that for many, we may be dosing beyond what is strictly necessary for clinical efficacy based in the standard approved doses.
It’s time to re-consider low doses regimen, ensuring sustainable access driven model of care to all patients without compromising patient safety or posing burden on the healthcare system.”
Michael Makris, Emeritus Professor of Haemostasis and Thrombosis at the University of Sheffield, shared a post on LinkedIn:
”The approved dose of Hemlibra (emicizumab) is generous, and smaller doses are likely to be effective.
You can read the arguments in my commentary published in the current issue of the Journal of Thrombosis and Haemostasis.”
Title: Is all the approved emicizumab dose essential?
Author: Michael Makris
Read the Full Article on JTH
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 23, 2026, 07:45Cerebral Venous Sinus Thrombosis: New Diagnostic Approaches
-
Jun 23, 2026, 07:07Jungmok Seo: A Quinone-Activated Hydrogel for Second-Scale Hemostasis and Suture-Free Surgical Sealing
-
Jun 23, 2026, 06:25Melissa Hollo: The Hidden Burden of Anemia in Cardiovascular Disease
-
Jun 23, 2026, 06:04William Wallace: Why Normal Bloodwork Doesn’t Always Mean Normal Iron Stores
-
Jun 23, 2026, 05:33Rob Maloney: Why Coordination Matters More Than Capacity
-
Jun 22, 2026, 21:06Marios Bantidos: Can a Routinely Available Metabolic Index Improve Prediction of Angiographic Outcomes in STEMI?
-
Jun 22, 2026, 20:53Kirti Gupta: What is a DVT Scan?
-
Jun 22, 2026, 20:47Ifeanyichukwu Ifechidere: Advancing Education, Research, and Laboratory Excellence in APS
-
Jun 22, 2026, 20:46Mohamed Abdel Moneim: Proud to Contribute to 2 Publications on Obesity and VTE Risk